These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21264227)

  • 1. TNFα cooperates with IFN-γ to repress Bcl-xL expression to sensitize metastatic colon carcinoma cells to TRAIL-mediated apoptosis.
    Liu F; Hu X; Zimmerman M; Waller JL; Wu P; Hayes-Jordan A; Lev D; Liu K
    PLoS One; 2011 Jan; 6(1):e16241. PubMed ID: 21264227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
    El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
    Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer].
    Zhu HB; Huang XF; Hu JZ; Zhou W; Chen W; Chen LL; He C
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):245-9. PubMed ID: 18788624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo.
    Yang D; Torres CM; Bardhan K; Zimmerman M; McGaha TL; Liu K
    J Immunol; 2012 May; 188(9):4441-9. PubMed ID: 22461695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-xL/Bax ratio is altered by IFNgamma in TNFalpha- but not in TRAIL-induced apoptosis in colon cancer cell line.
    Baillat G; Garrouste F; Remacle-Bonnet M; Marvaldi J; Pommier G
    Biochim Biophys Acta; 2005 Aug; 1745(1):101-10. PubMed ID: 16085058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria.
    Nagy K; Székely-Szüts K; Izeradjene K; Douglas L; Tillman M; Barti-Juhász H; Dominici M; Spano C; Luca Cervo G; Conte P; Houghton JA; Mihalik R; Kopper L; Peták I
    Pathol Oncol Res; 2006; 12(3):133-42. PubMed ID: 16998592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.
    Zhang JS; Herreros-Villanueva M; Koenig A; Deng Z; de Narvajas AA; Gomez TS; Meng X; Bujanda L; Ellenrieder V; Li XK; Kaufmann SH; Billadeau DD
    Cell Death Dis; 2014 Mar; 5(3):e1142. PubMed ID: 24675460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
    Hari Y; Harashima N; Tajima Y; Harada M
    Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAIL-induced cell death cooperates with IFN-gamma activation in the graft-versus-tumor effect against colon tumors.
    Tateishi K; Ohta M; Guleng B; Kanai F; Tanaka Y; Asaoka Y; Jazag A; Imamura J; Imamura T; Ijichi H; Ikenoue T; Kawakami T; Fukushima Y; Washida M; Sata M; Miyagishi M; Taira K; Yoshida H; Kawabe T; Omata M
    Int J Cancer; 2006 May; 118(9):2237-46. PubMed ID: 16331624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8.
    Häcker S; Dittrich A; Mohr A; Schweitzer T; Rutkowski S; Krauss J; Debatin KM; Fulda S
    Oncogene; 2009 Sep; 28(35):3097-110. PubMed ID: 19597472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
    Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
    Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J
    Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.
    Lacour S; Hammann A; Wotawa A; Corcos L; Solary E; Dimanche-Boitrel MT
    Cancer Res; 2001 Feb; 61(4):1645-51. PubMed ID: 11245478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma modulates TRAIL-mediated apoptosis in human colon carcinoma cells.
    Langaas V; Shahzidi S; Johnsen JI; Smedsrød B; Sveinbjørnsson B
    Anticancer Res; 2001; 21(6A):3733-8. PubMed ID: 11911240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL.
    Cha HY; Lee BS; Chang JW; Park JK; Han JH; Kim YS; Shin YS; Byeon HK; Kim CH
    Cancer Lett; 2016 Mar; 372(1):65-74. PubMed ID: 26721202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression.
    Tu SP; Sun YW; Cui JT; Zou B; Lin MC; Gu Q; Jiang SH; Kung HF; Korneluk RG; Wong BC
    Cancer; 2010 Mar; 116(5):1252-63. PubMed ID: 20082449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells.
    Kim SY; Lee DH; Song X; Bartlett DL; Kwon YT; Lee YJ
    Apoptosis; 2014 Nov; 19(11):1603-15. PubMed ID: 25156145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
    Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
    Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells.
    Büneker CK; Yu R; Deedigan L; Mohr A; Zwacka RM
    Cancer Lett; 2012 Mar; 316(2):168-77. PubMed ID: 22104728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aza-2'-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8.
    Fulda S; Debatin KM
    Oncogene; 2006 Aug; 25(37):5125-33. PubMed ID: 16607283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.